Ken Anderson has been Woodhaven’s managing partner since 2017, with over 30 years of experience in a variety of industries, with particular emphasis on government services, healthcare, and energy in the UK, US, Europe, and the Middle East. 

In 2020, Ken was senior advisor to the Saudi Arabian Minister of Health, helping design the new delivery model and implement the Saudi Healthcare Transformation Programme, Vision 2030. 

Previously, Ken was Vice Chairman of UBS’s global health advisory, advising, among others, GSK, HCA, the Swedish and UK Governments, Arcadia, Blackstone, Mubadala, TPG, Dell, and BP. Before that, Ken was Commercial Director General of the Department of Health and National Health Service, initiating privatisation-based NHS reforms.

Ken is an Adjunct Professor of Finance and Health Management at Imperial College Business School and sits on the board of Texas A&M University’s Biotechnology Commercialisation Company.